Medicinal treatment services for weight loss – September 2025
Updated 6 October 2025
© Crown copyright 2025
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-september-2025/medicinal-treatment-services-for-weight-loss-september-2025
1.1 Medicinal treatment services for weight-loss – September 2025
The following companies have amended their advertising following MHRA action on complaints to ensure that Prescription-Only Medicines (POMs) for weight loss (including reference to the class of medicines called GLP-1s, or to “weight loss injections” or similar) are not promoted to the public. Advertising Regulations prohibit the publishing of an advertisement to the public that is likely to lead to the use of a POM.
- Barrie Dear Limited t/a Dears Pharmacy
- MedExpress Enterprises Ltd t/a MedExpress
- Menwell Ltd t/a Voy
- Second Nature Healthy Habits Ltd t/a Second Nature
-
SwiftDoctor Ltd
- YM Pharma Group Ltd t/a YourMedicals
The list relates to specific advertising action taken on a particular date and is no endorsement of the ongoing practices of the website.
You can see details of MHRA guidance for providers that offer medicinal treatment services in Appendix 6 of the MHRA Blue Guide.